Nasus Pharma Ltd Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Nasus Pharma Ltd (NSRX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $145.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-25
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|
| 2025-12-31 | $145.00K 20-F · filed 2026-03-25 |